Incidence of Skin Changes in Patients with Myasthenia Gravis Prescribed Mycophenolate mofetil or Azathioprine (P1-1.Virtual)
Mycophenolate
DOI:
10.1212/wnl.98.18_supplement.271
Publication Date:
2023-12-06T21:32:24Z
AUTHORS (5)
ABSTRACT
To examine the impact of mycophenolate mofetil (MMF) and azathioprine (AZA) on incidence development skin lesions in patients with myasthenia gravis (MG).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....